While traditional cancer treatments such as chemotherapy and radiotherapy aim to destroy cancer cells, they can also damage healthy cells. This can cause many side effects in patients, ranging from hair loss to a weakened immune system. However, in recent years, there has been a significant development in cancer treatment: targeted therapies. So what do these therapies change, and why are they so important?
What Is Targeted Therapy? (So-Called “Smart Drugs”)
Targeted therapy is a treatment approach that uses drugs designed to act on specific molecules involved in the growth, division, and spread of cancer cells. These therapies have emerged from advances in understanding the biological mechanisms underlying cancer. As research has revealed that each cancer type possesses distinct genetic and molecular characteristics, it has become possible to develop drugs tailored to these specific features.
How Does It Work?
Targeted agents recognize and directly interfere with specific proteins or genetic alterations present in tumor cells. For example, in certain cancers, a protein known as HER2 may be overexpressed and drive uncontrolled cell growth. Drugs that specifically target HER2 can selectively affect cells expressing this protein, thereby slowing or halting disease progression. As a result, damage to healthy cells is minimized.
Because each patient’s tumor has a unique molecular profile, treatment must be individually tailored. Today, molecular analysis performed after biopsy enables clinicians to identify the most effective targeted therapy for many cancer patients. This approach allows patients to receive more effective treatment while avoiding the severe side effects commonly associated with conventional chemotherapy.
Although targeted therapies have fewer side effects than conventional treatments, they are not completely risk-free. Some side effects, such as skin rashes, diarrhea, and liver dysfunction, may occur. However, these side effects are generally milder, and the treatment process is better tolerated.
A New Phase in the Fight Against Cancer
Targeted therapies have been shown to both prolong survival and improve quality of life for many patients. Ongoing research suggests that continued advances in this field will lead to even more precise and effective treatment options. The goal is no longer merely to eliminate cancer, but to understand it in greater depth and control it through smarter, individualized strategies.
In this context, targeted therapies represent a critical milestone in cancer treatment, demonstrating how scientific progress can translate into tangible benefits for patients and ushering in a new era of precision oncology.